CNS Pharmaceuticals, Inc.

8-K Regulation FD disclosure Jul 2, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change May 4, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 30, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Regulation FD disclosure Mar 11, 2026 8-K Director or officer change Mar 2, 2026 8-K Director or officer change Feb 17, 2026 8-K Director or officer change Dec 17, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Nov 21, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Other events Jul 22, 2025 8-K Regulation FD disclosure Jul 15, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Entered a material agreement May 15, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 30, 2025 8-K Regulation FD disclosure Apr 9, 2025 8-K Other events Mar 31, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Other events Mar 20, 2025 8-K Modified rights of security holders; Other events Feb 21, 2025 8-K Regulation FD disclosure; Other events Jan 3, 2025 8-K Regulation FD disclosure Dec 11, 2024 8-K Shareholder vote results Dec 3, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Other events Nov 1, 2024 8-K Entered a material agreement; Other events Oct 24, 2024 8-K Other events Oct 23, 2024 8-K Delisting notice or listing-rule failure Sep 18, 2024 8-K Delisting notice or listing-rule failure Sep 12, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Other events Aug 7, 2024 8-K Other events Jul 30, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jul 30, 2024 8-K Entered a material agreement Jul 26, 2024 8-K Delisting notice or listing-rule failure Jul 24, 2024 8-K/A Other events Jul 12, 2024 8-K Other events Jul 9, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Jul 3, 2024